Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

aTyr Pharma Q3 EPS $(0.20) Beats $(0.23) Estimate, Sales $353.00K Miss $1.50M Estimate

Author: Benzinga Newsdesk | November 09, 2023 05:46pm
aTyr Pharma (NASDAQ:LIFE) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $(0.23) by 13.04 percent. This is a 56.52 percent increase over losses of $(0.46) per share from the same period last year. The company reported quarterly sales of $353.00 thousand which missed the analyst consensus estimate of $1.50 million by 76.47 percent.

Posted In: LIFE


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist